Amphastar Sues FDA Over Raw Heparin Shipments
Amphastar Pharmaceuticals Inc. has filed a lawsuit asking a federal judge to force the U.S. Food and Drug Administration to release two shipments of raw heparin from a Chinese subsidiary that...To view the full article, register now.
Already a subscriber? Click here to view full article